A non-invasive, urine-sample-based diagnostic kit for prostate cancer detection and risk assessment. The kit utilizes PSA N-glycosylation analysis to detect asparagine-linked carbohydrates of PSA, providing comprehensive clinical insights into prostate cancer-related alterations. It employs recombin...
Manufactured by
iPASY Technologies Kft
Veszprém, Hungary
iPASy is revolutionizing prostate cancer screening with a urine-based, non-invasive diagnostic that detects disease-specific glycan patterns of urinary PSA, offering up to six-times higher specificity than blood-based tests. Our vision is to make prostate cancer detection accurate, accessible, and patient-friendly worldwide , with upcoming launches in Europe and the U.S. in collaboration with Mayo Clinic .
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Zybio Inc.
China · 1 relevant product
BEACON DIAGNOSTICS PVT. LTD.
India · 1 relevant product
Berkeley Health Ltd
United Kingdom · 2 relevant products
79 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →17 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 108 closest product alternatives
Zybio Inc. · China
Immunoassay for prostate-specific antigen measurement in prostate cancer screening. Provides quantitative measurement for clinical decision-making.
BEACON DIAGNOSTICS PVT. LTD. · India
Prostate-specific antigen assay for screening and monitoring of prostate cancer. Quantitative measurement of PSA in serum samples.
Berkeley Health Ltd · United Kingdom
Rapid home test kit for semi-quantitative detection of prostate-specific antigen in human whole blood. Enables self-screening for prostate health status with results available within 15 minutes. ISO 13485:2016 certified for accuracy and reliability.
105 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products